CAXTON CORP - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 83 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2013. The put-call ratio across all filers is 0.12 and the average weighting 1.1%.

Quarter-by-quarter ownership
CAXTON CORP ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2016$5,684,000
+8.8%
21,842,662
+0.3%
6.41%
-11.1%
Q1 2016$5,225,000
-31.8%
21,771,847
+0.1%
7.21%
-77.6%
Q4 2015$7,659,000
-88.1%
21,758,894
-41.4%
32.13%
-63.1%
Q3 2015$64,599,000
-21.9%
37,126,140
+0.0%
87.13%
-0.5%
Q2 2015$82,762,000
+15.1%
37,113,186
+0.1%
87.59%
+2.1%
Q1 2015$71,893,000
-10.2%
37,058,136
+22.7%
85.78%
-6.8%
Q4 2014$80,025,000
-12.0%
30,197,945
+0.0%
92.06%
-1.6%
Q3 2014$90,887,000
-25.7%
30,194,898
+1.0%
93.55%
-0.7%
Q2 2014$122,258,000
-1.0%
29,891,849
+4.4%
94.25%
+0.0%
Q1 2014$123,436,000
-17.7%
28,639,349
-0.0%
94.21%
-1.1%
Q4 2013$150,057,000
+0.6%
28,641,849
+21.2%
95.29%
-4.6%
Q3 2013$149,133,000
+26.5%
23,634,349
+0.0%
99.87%
+0.1%
Q2 2013$117,923,000
-33.2%
23,631,849
+15.1%
99.78%
+0.0%
Q1 2013$176,554,000
-4.6%
20,529,561
+0.0%
99.77%
+25.4%
Q4 2012$185,156,00020,527,27779.57%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q2 2013
NameSharesValueWeighting ↓
CAXTON CORP 21,696,894$7,637,00032.03%
Anson Funds Management LP 989,204$348,0000.11%
CAXTON CORP 62,000$22,0000.09%
McQueen, Ball & Associates Inc. 102,742$36,0000.03%
Sheaff Brock Investment Advisors, LLC 320,000$113,0000.01%
Roundview Capital LLC 21,100$7,0000.00%
QCM Cayman, Ltd. 11,197$4,0000.00%
ZACKS INVESTMENT MANAGEMENT 193,406$68,0000.00%
Renaissance Technologies 2,504,200$881,0000.00%
Squarepoint Ops LLC 56,800$20,0000.00%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders